Tags |
|
|
Links |
|
|
Main Subject - Top 5 Mistakes List Builders Make
1) Not building to a niche
When you are building a list, the more general your list demographics, the more diffic
When you are building a list, the more general your list demographics, the more diffic
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ult it is to sell to the list (and isn’t that your purpose?). For example, if you build a list of animal lovers,
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
that might include pet owners, environmental activists, nature walkers, and people who just enjoy watching animal
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
movies. So when you try to mail this list what do you mail? Anything you mail will not be a strong fit for the
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ntire list, only for one segment of the list. Correction to mistake: Tightly target your list or create multiple
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
lists, one for each category of animal lovers.
2) Not creating a relationship with your list
It is easy when y
2) Not creating a relationship with your list
It is easy when y
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ou first begin building a list to think more about building a list and driving traffic to the list than to be thin
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ing about the people on the list. If you subscribe people to this list, but do not mail them after the confirmati
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
on email for two months, when you do mail them they do not know who you are and are likely to unsubscribe. Correc
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
tion: immediately begin to build a relationship via email with your list, even if you only have 5 on your list.
3
3
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
Mailing your list rather than the people on the list
Think about when you receive an email. If the email reads
Think about when you receive an email. If the email reads
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
, ‘Sean, I’d like to share something with you today’ are you more or less likely to read it than one that reads, ‘
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
To all my newsletter subscribers, I’d like to share something with you‘? You must treat your list like it is a gr
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
oup of friends, not a list of email addresses.
4) Trying to sell all the time.
We all know you are in business.
4) Trying to sell all the time.
We all know you are in business.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
That is what your signature line is for. When you simply try to sell hard in every email, you will get unsubscr
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ibes, and the ones that don’t unsubscribe aren’t reading your emails anyhow. Correction: Give your subscribers u
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
seful information in your emails. You can occasionally send a recommendation to a product you personally use or k
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ow will be useful to your readers, but do it sparingly.
5) Not communicating with your list. Find out what the
5) Not communicating with your list. Find out what the
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
y want to hear about. Ask questions. Send your list a survey. Ask them what are their top five questions for th
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e niche they are in. Then when they answer the survey, be sure to answer all the questions in the next few emails
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/62443/mainsubjects-Top-5-Mistakes-List-Builders-Make.html">Top 5 Mistakes List Builders Make</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/62443/mainsubjects-Top-5-Mistakes-List-Builders-Make.html]Top 5 Mistakes List Builders Make[/url]
Related Articles:
How To Benefit From Freelancer Jobs And Freelance Talent
The Best Way To Find A Legitimate Home Business Opportunity
Bookmark it:
|